[HTML][HTML] Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair

K Salata, M Syed, MA Hussain, R Eikelboom… - Journal of vascular …, 2018 - Elsevier
Objective The objective of this study was to summarize the literature regarding the effects of
renin-angiotensin system blockade (RASB) using angiotensin-converting enzyme inhibitors …

Systematic review and meta-analysis of contemporary abdominal aortic aneurysm growth rates

CF Prendes, RG e Melo, D Caldeira, M D'Oria… - European Journal of …, 2023 - Elsevier
Objective To evaluate the contemporary growth rate of small abdominal aortic aneurysms
(AAAs) in view of recent epidemiological changes, such as decreasing smoking rates and …

[HTML][HTML] Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms

MJ Sweeting, SG Thompson, LC Brown… - Journal of vascular …, 2010 - Elsevier
OBJECTIVES: To evaluate whether either angiotensin converting enzyme (ACE) inhibitors
or other classes of antihypertensive drug attenuate or increase growth rates of small …

Temporal trends in abdominal aortic aneurysmal disease: a nationwide cohort study on cardiovascular morbidity and medical cardioprotective therapy

CW Nicolajsen, M Søgaard, N Eldrup… - European Journal of …, 2022 - academic.oup.com
Aims Abdominal aortic aneurysmal disease is associated with increased risk of
cardiovascular morbidity and death, which potentially can be reduced with cardioprotective …

[HTML][HTML] Status of diagnosis and therapy of abdominal aortic aneurysms

J Lin, S Chen, Y Yao, M Yan - Frontiers in cardiovascular medicine, 2023 - frontiersin.org
Abdominal aortic aneurysms (AAAs) are characterized by localized dilation of the abdominal
aorta. They are associated with several serious consequences, including compression of …

[HTML][HTML] A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion

H Takagi, M Matsui, T Umemoto - Journal of vascular surgery, 2010 - Elsevier
BACKGROUND: Despite the absence of a relationship between cholesterol and abdominal
aortic aneurysm (AAA) expansion, there is evidence from a number of studies to suggest that …

Atherosclerosis and abdominal aortic aneurysm: cause, response, or common risk factors?

J Golledge, PE Norman - Arteriosclerosis, thrombosis, and …, 2010 - Am Heart Assoc
Abdominal aortic aneurysm (AAA) rupture has been recognized as a significant cause of
mortality for adults aged 60 years in the developed world for some time. 1 AAAs are usually …

[HTML][HTML] Comparing American, European and Asian practice guidelines for aortic diseases

J Rozado, M Martin, I Pascual… - Journal of thoracic …, 2017 - ncbi.nlm.nih.gov
The aortic disease comprises a group of different pathologies of high prevalence,
seriousness and ever changing by the medical and surgical investigations. Therefore …

Efficacy of telmisartan to slow growth of small abdominal aortic aneurysms: a randomized clinical trial

J Golledge, J Pinchbeck, SM Tomee… - JAMA …, 2020 - jamanetwork.com
Importance Currently there is no drug therapy for abdominal aortic aneurysm (AAA).
Objective To test the efficacy of the angiotensin receptor blocker telmisartan in slowing AAA …

The association between body mass index and abdominal aortic aneurysm growth: a systematic review

H Takagi, T Umemoto - Vasa, 2016 - econtent.hogrefe.com
Diabetes, a state of relative insulin resistance, is negatively associated with both the
presence and growth abdominal aortic aneurysms (AAA), which could suggest a protective …